AUTHOR=Chen Chun-Fa , Zhang Yu-Ling , Cai Ze-Long , Sun Shu-Ming , Lu Xiao-Feng , Lin Hao-Yu , Liang Wei-Quan , Yuan Ming-Heng , Zeng De 

TITLE=Predictive Value of Preoperative Multidetector-Row Computed Tomography for Axillary Lymph Nodes Metastasis in Patients With Breast Cancer

JOURNAL=Frontiers in Oncology

VOLUME=8

YEAR=2019

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2018.00666

DOI=10.3389/fonc.2018.00666

ISSN=2234-943X

ABSTRACT=<p><bold>Introduction:</bold> Axillary lymph nodes (ALN) status is an essential component in tumor staging and treatment planning for patients with breast cancer. The aim of present study was to evaluate the predictive value of preoperative multidetector-row computed tomography (MDCT) for ALN metastasis in breast cancer patients.</p><p><bold>Methods:</bold> A total of 148 cases underwent preoperative MDCT examination and ALN surgery were eligible for the study. Logistic regression analysis of MDCT variates was used to estimate independent predictive factors for ALN metastasis. The prediction of ALN metastasis was determined with MDCT variates through receiver operating characteristic (ROC) analysis.</p><p><bold>Results:</bold> Among the 148 cases, 61 (41.2%) cases had ALN metastasis. The cortical thickness in metastatic ALN was significantly thicker than that in non-metastatic ALN (7.5 ± 5.0 mm vs. 2.6 ± 2.8 mm, <italic>P</italic> &lt; 0.001). Multi-logistic regression analysis indicated that cortical thickness of &gt;3 mm (OR: 12.32, 95% CI: 4.50–33.75, <italic>P</italic> &lt; 0.001) and non-fatty hilum (OR: 5.38, 95% CI: 1.51–19.19, <italic>P</italic> = 0.009) were independent predictors for ALN metastasis. The sensitivity, specificity and AUC of MDCT for ALN metastasis prediction based on combined-variated analysis were 85.3%, 87.4%, and 0.893 (95% CI: 0.832–0.938, <italic>P</italic> &lt; 0.001), respectively.</p><p><bold>Conclusions:</bold> Cortical thickness (&gt;3 mm) and non-fatty hilum of MDCT were independent predictors for ALN metastasis. MDCT is a potent imaging tool for predicting ALN metastasis in breast cancer. Future prospective study on the value of contrast enhanced MDCT in preoperative ALN evaluation is warranted.</p>